Release Date: 2024-06-19

Palliative Care for Metastatic Prostate Cancer

Release Date: 2024-06-19

Happiness is one of the oldest and most intriguing topics in human history. The definition of happiness and how to achieve it have been questioned since ancient times. Research shows that the foundation of happiness lies in the level of social communication and interaction. The most basic area of interaction and communication for individuals is [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inCurrent Management of Metastatic Prostate Cancer
    First Page167
    Last Page184
    DOIhttps://doi.org/10.69860/nobel.9786053359142.17
    Page Count18
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
    Happiness is one of the oldest and most intriguing topics in human history. The definition of happiness and how to achieve it have been questioned since ancient times. Research shows that the foundation of happiness lies in the level of social communication and interaction. The most basic area of interaction and communication for individuals is their family. Therefore, individuals who are happy in their family life tend to reflect this happiness in their work and other social relationships. Thus, by following certain rules and taking necessary precautions during the process of establishing and maintaining a family through marriage, we can achieve a happy family life and, consequently, a happy life.
    If marriage and family life bring us so much joy, we need to appreciate their value. Imagine having a latest model luxury car; you would enjoy driving it, right? But first and foremost, you must have a driver’s license. Similarly, before getting married, we must receive education on marriage and obtain a marriage license. Governments should ensure that those without a marriage license are not allowed to marry. If you neglect your vehicle’s monthly and annual maintenance and do not comply with traffic rules, an accident is inevitable. We take our damaged vehicle to a repair shop. Likewise, in marriages, it is necessary to attend marriage therapy sessions periodically and seek expert support for problems encountered during disagreements. Just as polishing and washing our car from time to time improves its appearance and provides satisfaction, spending quality and special time as a family is essential for relief and peace within the family.
    Achieving happiness within the family is possible by taking advantage of the wonderful opportunities offered by marriage. The most important aspects include not only dedicating special time for each other and the children but also getting to know oneself, making time for self-care, understanding the partner’s expectations through empathy, and ultimately fostering a sense of ""us."" While achieving all these, it is crucial to recognize sexuality as a beautiful fruit of marriage and to regularly enjoy this aspect.
    In this book, we share the secrets of how to achieve a happy family and marriage with a team of family and marriage counselors. I wish you a pleasant reading experience.

    Ferhat Yakup Suceken (Author)
    MD, Saglık Bilimleri Universty
    https://orcid.org/0000-0001-7605-4353
    3Ferhat Yakup Suceken is an Specialist Doctor of Urology. After graduated from Kocaeli University, Faculty of Medicine, he pursued Urological Surgery residency at University of Health Sciences Ümraniye Teaching Hospital. His career includes varios academic positions in different institutions. He has been a part of the Ümraniye Teaching Hospital. His expertise covers the treatments of, urological cancers and minimally invasive endourological surgery including laparoscopic surgery, reconstructive urology and andrology.

    Ahmet Tahra (Author)
    MD, Associate Professor of Urology, Saglık Bilimleri Universty
    https://orcid.org/0000-0002-5158-5630
    3Ahmet Tahra is an Associate Professor of Urology. After graduated from Ege University, Faculty of Medicine, he pursued Urological Surgery residency at University of Health Sciences Ümraniye Teaching Hospital. His career includes varios academic positions in different institutions. He has been a part of the University of Health Sciences, Ümraniye Teaching Hospital. His expertise covers the treatments of, urological cancers and minimally invasive endourological surgery including robotic surgery, reconstructive urology and functional urology.

    • Chen J, Zhang D, Yan W, Yang D, Shen B. Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era. Biomed Res Int. 2013;2013:901578.

    • Indrianto YL, Nugroho E, Tjandra BA, Pramusinta WA, Wijaya MP. The Efficacy of Prostatic Artery Embolization (PAE) as Palliative Therapy in Prostate Cancer. World J Adv Res Rev. 2024;21(01):1630–7.

    • Belkahla S, Nahvi I, Biswas S, Nahvi I, Ben Amor N. Advances and development of prostate cancer, treatment, and strategies: A systemic review. Front cell Dev Biol. 2022;10:991330.

    • Rosa WE, Ferrell BR, Mason DJ. Integration of Palliative Care Into All Serious Illness Care as A Human Right. JAMA Heal forum. 2021 Apr;2(4):e211099.

    • Gramling R, Stanek S, Han PKJ, Duberstein P, Quill TE, Temel JS, et al. Distress Due to Prognostic Uncertainty in Palliative Care: Frequency, Distribution, and Outcomes among Hospitalized Patients with Advanced Cancer. J Palliat Med. 2018 Mar;21(3):315–21.

    • Sanford MT, Greene KL, Carroll PR. The argument for palliative care in prostate cancer. Transl Androl Urol. 2013 Dec;2(4):278–80.

    • Brawley OW. Trends in prostate cancer in the United States. J Natl Cancer Inst Monogr. 2012 Dec;2012(45):152–6.

    • Paller CJ, Antonarakis ES. Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions. Clin Adv Hematol Oncol. 2013 Jan;11(1):14–23.

    • Koo KC. Palliative Care for Metastatic Symptomatic CRPC. In: Kim CS, editor. Management of Advanced Prostate Cancer [Internet]. Singapore: Springer Singapore; 2018. p. 197–201. Available from: https://doi.org/10.1007/978-981-10-6943-7_25

    • Saad F, Miller K. Treatment options in castration-resistant prostate cancer: current therapies and emerging docetaxel-based regimens. Urol Oncol. 2014 Feb;32(2):70–9.

    • Torvinen S, Färkkilä N, Sintonen H, Saarto T, Roine RP, Taari K. Health-related quality of life in prostate cancer. Acta Oncol. 2013 Aug;52(6):1094–101.

    • Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009 Aug;302(7):741–9.

    • Gade G, Venohr I, Conner D, McGrady K, Beane J, Richardson RH, et al. Impact of an inpatient palliative care team: a randomized control trial. J Palliat Med. 2008 Mar;11(2):180–90.

    • Yennurajalingam S, Atkinson B, Masterson J, Hui D, Urbauer D, Tu S-M, et al. The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. J Palliat Med. 2012 Jan;15(1):20–4.

    • M. R. 2011 Annual Assembly of the American Academy of Hospice and Palliative Medicine. In p. Feb 16-19.

    • Dalal S, Palla S, Hui D, Nguyen L, Chacko R, Li Z, et al. Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist. 2011;16(1):105–11.

    • Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol Off J Am Soc Clin Oncol. 2012 Mar;30(8):880–7.

    • Foley KM, Gelband H, editors. No Title. Washington (DC); 2001.

    • Levy MH, Back A, Benedetti C, Billings JA, Block S, Boston B, et al. NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Canc Netw. 2009 Apr;7(4):436–73.

    • Won ACM, Gurney H, Marx G, De Souza P, Patel MI. Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer. BJU Int. 2013 Aug;112(4):E250-5.

    • Grimm MO, Kamphausen S, Hugenschmidt H, Stephan-Odenthal M, Ackermann R, Vögeli TA. Clinical outcome of patients with lymph node positive prostate cancer after radical prostatectomy versus androgen deprivation. Eur Urol. 2002 Jun;41(6):628–34.

    • Qin XJ, Ma CG, Ye DW, Yao XD, Zhang SL, Dai B, et al. Tumor cytoreduction results in better response to androgen ablation-a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer. Urol Oncol Semin Orig Investig. 2012;30(2):145–9.

    • Piper C, Porres D, Pfister D, Heidenreich A. The role of palliative surgery in castration-resistant prostate cancer. Curr Opin Support Palliat Care. 2014 Sep;8(3):250–7.

    • Krupski TL, Stukenborg GJ, Moon K, Theodorescu D. The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer. BJU Int. 2010 Nov;106(10):1477–83.

    • Michielsen DPJ, Coomans D, Engels B, Braeckman JG. Bipolar versus monopolar technique for palliative transurethral prostate resection. Arch Med Sci. 2010 Oct;6(5):780–6.

    • Malling B, Røder MA, Lindh M, Frevert S, Brasso K, Lönn L. Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series. Cardiovasc Intervent Radiol. 2019 Oct;42(10):1405–12.

    • Wang MQ, Zhang JL, Duan F, Yuan B, Xin H, Fu JX, et al. Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):88–95.

    • Cameron MG, Kersten C, Guren MG, Fosså SD, Vistad I. Palliative pelvic radiotherapy of symptomatic incurable prostate cancer - a systematic review. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2014 Jan;110(1):55–60.

    • Banning A, Sjøgren P, Henriksen H. Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic. Pain. 1991 Apr;45(1):45–8.

    • Nielsen OS, Munro AJ, Tannock IF. Bone metastases: pathophysiology and management policy. J Clin Oncol Off J Am Soc Clin Oncol. 1991 Mar;9(3):509–24.

    • Misra S, Coker C, Richenberg J. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right? Int Urol Nephrol. 2013 Jun;45(3):627–32.

    • Song H-Y, Kim CS, Jeong IG, Yoo D, Kim JH, Nam DH, et al. Placement of retrievable self-expandable metallic stents with barbs into patients with obstructive prostate cancer. Eur Radiol. 2013 Mar;23(3):780–5.

    • Quella SK, Loprinzi CL, Sloan J, Novotny P, Perez EA, Burch PA, et al. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol. 1999 Jul;162(1):98–102.

    • EAU Guidelines. Edn Present EAU Annu Congr Milan 2023. ISBN 978-9.

    • Rabow MW, Lee MX. Palliative care in castrate-resistant prostate cancer. Urol Clin North Am. 2012 Nov;39(4):491–503.

    • Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004 Apr;350(16):1655– 64.

    • Wagner G. Frequency of pain in patients with cancer. Recent results cancer Res Fortschritte der Krebsforsch Prog dans les Rech sur le cancer. 1984;89:64–71.

    • Porter AT, McEwan AJ, Powe JE, Reid R, McGowan DG, Lukka H, et al. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys. 1993 Apr;25(5):805–13.

    • Chaichana KL, Pendleton C, Sciubba DM, Wolinsky J-P, Gokaslan ZL. Outcome following decompressive surgery for different histological types of metastatic tumors causing epidural spinal cord compression. Clinical article. J Neurosurg Spine. 2009 Jul;11(1):56–63.

    • Tiedje LB, Kingry MJ, Stommel M. Patient attitudes concerning health behaviors during pregnancy: initial development of a questionnaire. Health Educ Q. 1992;19(4):481– 93.

    • Pathological fractures due to bone metastases. Vol. 283, British medical journal (Clinical research ed.). England; 1981. p. 748.

    • Galasko CS. The management of skeletal metastases. J R Coll Surg Edinb. 1980 May;25(3):144–61.

    • Frankel BM, Monroe T, Wang C. Percutaneous vertebral augmentation: an elevation in adjacent-level fracture risk in kyphoplasty as compared with vertebroplasty. Spine J. 2007;7(5):575–82.

    • Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2002 Oct;94(19):1458–68.

    • Cereceda LE, Flechon A, Droz J-P. Management of vertebral metastases in prostate cancer: a retrospective analysis in 119 patients. Clin Prostate Cancer. 2003 Jun;2(1):34–40.

    • Fizazi K, Carducci M, Smith M, Damião R, Brown J, Karsh L, et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet (London, England). 2011 Mar;377(9768):813–22.

    • Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol Off J Eur Soc Med Oncol. 2008 Mar;19(3):420–32.

    • Sartor O, Reid RH, Hoskin PJ, Quick DP, Ell PJ, Coleman RE, et al. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. Urology. 2004 May;63(5):940–5.

    • Roqué I Figuls M, Martinez-Zapata MJ, Scott-Brown M, Alonso-Coello P. Radioisotopes for metastatic bone pain. Cochrane database Syst Rev. 2011 Jul;(7):CD003347.

    • Tu SM, Millikan RE, Mengistu B, Delpassand ES, Amato RJ, Pagliaro LC, et al. Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet (London, England). 2001 Feb;357(9253):336–41.

    • Henriksen G, Fisher DR, Roeske JC, Bruland ØS, Larsen RH. Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice. J Nucl Med. 2003 Feb;44(2):252–9.

    • Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013 Jul;369(3):213–23.

    • Grossman SA, Lossignol D. Diagnosis and treatment of epidural metastases. Oncology (Williston Park). 1990 Apr;4(4):47–54; discussion 55, 58.

    • Lawton AJ, Lee KA, Cheville AL, Ferrone ML, Rades D, Balboni TA, et al. Assessment and Management of Patients With Metastatic Spinal Cord Compression: A Multidisciplinary Review. J Clin Oncol Off J Am Soc Clin Oncol. 2019 Jan;37(1):61–71.

    Share This Chapter!